Powered by

Stock Weekly: Medicenna Therapeutics (MDNA:CAD4.86) sinks 4.1% - trailing 85% of stocks

Dec 18, 2020 - News Bites Canadian Markets
Board and Executive Moves-Event Announcements-Financial Results

CANADIAN WEEKLY STOCK REPORT

Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 12th largest Biotechnology company by market cap, has dropped 21.0c (or 4.1%) in the past week to close at CAD4.86. Compared with the S&P/TSX 60 Index which fell 1.6 points (or 0.1%) in the week, this represented a relative price change of -4.0%.

In the Canadian market of 1,620 stocks and 58 units traded today, the stock has a 6-month relative strength of 15 indicating it is trailing 85.0% of the market.

The price ranged between a low of 4.83 on Thursday, Dec 17 and a high of 5.07 on Friday, Dec 11. In the past week the market cap has declined by CAD10.3 million ($8.1 million) to CAD237.8 mi...